Logo image of SENS

SENSEONICS HOLDINGS INC (SENS) Stock Price, Forecast & Analysis

USA - NASDAQ:SENS - US81727U3032 - Common Stock

5.98 USD
+0.08 (+1.36%)
Last: 11/18/2025, 8:00:02 PM
5.9212 USD
-0.06 (-0.98%)
Pre-Market: 11/19/2025, 8:00:00 AM

SENS Key Statistics, Chart & Performance

Key Statistics
Market Cap243.57M
Revenue(TTM)22.47M
Net Income(TTM)-68.21M
Shares40.73M
Float36.95M
52 Week High28
52 Week Low5
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.25
PEN/A
Fwd PEN/A
Earnings (Next)03-02 2026-03-02/amc
IPO2015-03-04
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


SENS short term performance overview.The bars show the price performance of SENS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

SENS long term performance overview.The bars show the price performance of SENS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of SENS is 5.98 USD. In the past month the price decreased by -21.63%. In the past year, price decreased by -5.38%.

SENSEONICS HOLDINGS INC / SENS Daily stock chart

SENS Latest News, Press Relases and Analysis

SENS Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 26.05 226.26B
ISRG INTUITIVE SURGICAL INC 63.5 196.01B
BSX BOSTON SCIENTIFIC CORP 33.63 147.02B
SYK STRYKER CORP 27.3 137.45B
BDX BECTON DICKINSON AND CO 13.34 55.13B
IDXX IDEXX LABORATORIES INC 53.15 53.62B
EW EDWARDS LIFESCIENCES CORP 32.7 49.34B
RMD RESMED INC 24.87 35.93B
GEHC GE HEALTHCARE TECHNOLOGY 15.47 32.42B
DXCM DEXCOM INC 32.35 23.60B
PODD INSULET CORP 72.97 23.47B
ZBH ZIMMER BIOMET HOLDINGS INC 11.01 17.65B

About SENS

Company Profile

SENS logo image Senseonics Holdings Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Germantown, Maryland and currently employs 117 full-time employees. The company went IPO on 2015-03-04. Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.

Company Info

SENSEONICS HOLDINGS INC

20451 Seneca Meadows Pkwy

Germantown MARYLAND 20876 US

CEO: Timothy T. Goodnow

Employees: 117

SENS Company Website

SENS Investor Relations

Phone: 13015157260

SENSEONICS HOLDINGS INC / SENS FAQ

Can you describe the business of SENSEONICS HOLDINGS INC?

Senseonics Holdings Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Germantown, Maryland and currently employs 117 full-time employees. The company went IPO on 2015-03-04. Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.


What is the current price of SENS stock?

The current stock price of SENS is 5.98 USD. The price increased by 1.36% in the last trading session.


Does SENSEONICS HOLDINGS INC pay dividends?

SENS does not pay a dividend.


What is the ChartMill rating of SENSEONICS HOLDINGS INC stock?

SENS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What sector and industry does SENSEONICS HOLDINGS INC belong to?

SENSEONICS HOLDINGS INC (SENS) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


When does SENSEONICS HOLDINGS INC (SENS) report earnings?

SENSEONICS HOLDINGS INC (SENS) will report earnings on 2026-03-02, after the market close.


SENS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SENS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to SENS. While SENS seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SENS Financial Highlights

Over the last trailing twelve months SENS reported a non-GAAP Earnings per Share(EPS) of -1.25. The EPS decreased by -861.54% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -45.39%
ROE -72.01%
Debt/Equity 0.37
Chartmill High Growth Momentum
EPS Q2Q%-975%
Sales Q2Q%89.89%
EPS 1Y (TTM)-861.54%
Revenue 1Y (TTM)0.37%

SENS Forecast & Estimates

14 analysts have analysed SENS and the average price target is 19.3 USD. This implies a price increase of 222.66% is expected in the next year compared to the current price of 5.98.

For the next year, analysts expect an EPS growth of -1187.15% and a revenue growth 62.97% for SENS


Analysts
Analysts75.71
Price Target19.3 (222.74%)
EPS Next Y-1187.15%
Revenue Next Year62.97%

SENS Ownership

Ownership
Inst Owners18.56%
Ins Owners2.78%
Short Float %N/A
Short Ratio0.6